Construction and Validation of a Nomogram for Patients with Lentigo Maligna Melanoma: A SEER-based Study
Abstract
predicted the 1-, 3-, and 5-year overall survival (OS) rates of patients with lentigo maligna melanoma (LMM). Method: Clinical data
from 7, 833 SEER database LMM patients (2010-2015) were split 7:3 into training and validation cohorts. Univariate and multivariate
Cox regression on the training cohort identified independent prognostic factors, used to develop and validate a nomogram predicting 1,
3, and 5-year OS. Nomogram performance was assessed using C-index, calibration curves, ROC curves, and Kaplan-Meier curves analyzed survival differences between high- and low-risk groups defined by the nomogram. Result: Age, sex, primary site of occurrence,
AJCC stage, T stage, M stage, and surgical intervention were identified as independent prognostic factors affecting the outcomes of lentigo maligna melanoma.
Keywords
Full Text:
PDFReferences
[1] Karponis D, Stratigos IA, Joshy J, Craig PJ, Mistry K, van Bodegraven B, Venables ZC, Levell NJ. Lentigo maligna: a review. Clin Exp
Dermatol. 2024 Feb 14; 49(3):218-225. https://doi.org/10.1093/ced/llad394. PMID: 37966718.
[2] Drakensj IRT, Hedblad MA, Coln Cervantes E, Girnita A. Nevus-associated Lentigo Maligna and Lentigo Maligna Melanoma,
Clinicopathological Features. Acta Derm Venereol. 2024 Apr 17; 104: adv18381. https://doi.org/ 10.2340/actadv.v104.18381. PMID:
38629956; PMCID: PMC11040587.
[3] Gong X, Zhang Y, Yuan M, Wang Y, Xia C, Wang Y, Liu X, Ling T. Prognostic nomogram for external ear melanoma patients in the
elderly: a SEER-based study. J Cancer Res Clin Oncol. 2023 Oct; 149(13):12241-12248. https://doi.org/ 10.1007/s00432-023-05098-y.
Epub 2023 Jul 11. PMID: 37434093.
DOI: http://dx.doi.org/10.70711/pmr.v2i4.6122
Refbacks
- There are currently no refbacks.